[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Adalimumab Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect

September 2023 | 107 pages | ID: GADCD85042DBEN
Maia Research

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question


Adalimumab, sold under the brand name Humira among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis.

The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Adalimumab market covering all its essential aspects.

For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.

In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.

Key players in the global Adalimumab market are covered in Chapter 9:

Boehringer Ingelheim
Novartis AG
Pfizer
Biogen
Mylan
AbbVie
Sandoz
Amgen

In Chapter 5 and Chapter 7.3, based on types, the Adalimumab market from 2017 to 2027 is primarily split into:

Rheumatoid Arthritis
Psoriatic Arthritis
Psoriasis
Crohn’s disease
Ulcerative colitis


In Chapter 6 and Chapter 7.4, based on applications, the Adalimumab market from 2017 to 2027 covers:

Adults
Children

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:

United States

Europe

China

Japan

India

Southeast Asia

Latin America

Middle East and Africa

Client Focus

1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Adalimumab market?

Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Adalimumab Industry.

2. How do you determine the list of the key players included in the report?

With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.

Please find the key player list in Summary.

3. What are your main data sources?

Both Primary and Secondary data sources are being used while compiling the report.

Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.

Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.

Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.

4. Can I modify the scope of the report and customize it to suit my requirements?

Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.

Outline

Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.

Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.

Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.

Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.

Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.

Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.

Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.

Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.

Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.

Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.

Chapter 11 introduces the market research methods and data sources.

Years considered for this report:

Historical Years: 2017-2021

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2022-2027

1 ADALIMUMAB MARKET OVERVIEW

1.1 Product Overview and Scope of Adalimumab Market
1.2 Adalimumab Market Segment by Type
  1.2.1 Global Adalimumab Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Adalimumab Market Segment by Application
  1.3.1 Adalimumab Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Adalimumab Market, Region Wise (2017-2027)
  1.4.1 Global Adalimumab Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
  1.4.2 United States Adalimumab Market Status and Prospect (2017-2027)
  1.4.3 Europe Adalimumab Market Status and Prospect (2017-2027)
  1.4.4 China Adalimumab Market Status and Prospect (2017-2027)
  1.4.5 Japan Adalimumab Market Status and Prospect (2017-2027)
  1.4.6 India Adalimumab Market Status and Prospect (2017-2027)
  1.4.7 Southeast Asia Adalimumab Market Status and Prospect (2017-2027)
  1.4.8 Latin America Adalimumab Market Status and Prospect (2017-2027)
  1.4.9 Middle East and Africa Adalimumab Market Status and Prospect (2017-2027)
1.5 Global Market Size of Adalimumab (2017-2027)
  1.5.1 Global Adalimumab Market Revenue Status and Outlook (2017-2027)
  1.5.2 Global Adalimumab Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Adalimumab Market

2 INDUSTRY OUTLOOK

2.1 Adalimumab Industry Technology Status and Trends
2.2 Industry Entry Barriers
  2.2.1 Analysis of Financial Barriers
  2.2.2 Analysis of Technical Barriers
  2.2.3 Analysis of Talent Barriers
  2.2.4 Analysis of Brand Barrier
2.3 Adalimumab Market Drivers Analysis
2.4 Adalimumab Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Adalimumab Industry Development Trends under COVID-19 Outbreak
  2.7.1 Global COVID-19 Status Overview
  2.7.2 Influence of COVID-19 Outbreak on Adalimumab Industry Development

3 GLOBAL ADALIMUMAB MARKET LANDSCAPE BY PLAYER

3.1 Global Adalimumab Sales Volume and Share by Player (2017-2022)
3.2 Global Adalimumab Revenue and Market Share by Player (2017-2022)
3.3 Global Adalimumab Average Price by Player (2017-2022)
3.4 Global Adalimumab Gross Margin by Player (2017-2022)
3.5 Adalimumab Market Competitive Situation and Trends
  3.5.1 Adalimumab Market Concentration Rate
  3.5.2 Adalimumab Market Share of Top 3 and Top 6 Players
  3.5.3 Mergers & Acquisitions, Expansion

4 GLOBAL ADALIMUMAB SALES VOLUME AND REVENUE REGION WISE (2017-2022)

4.1 Global Adalimumab Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Adalimumab Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Adalimumab Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Adalimumab Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.4.1 United States Adalimumab Market Under COVID-19
4.5 Europe Adalimumab Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.5.1 Europe Adalimumab Market Under COVID-19
4.6 China Adalimumab Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.6.1 China Adalimumab Market Under COVID-19
4.7 Japan Adalimumab Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.7.1 Japan Adalimumab Market Under COVID-19
4.8 India Adalimumab Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.8.1 India Adalimumab Market Under COVID-19
4.9 Southeast Asia Adalimumab Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.9.1 Southeast Asia Adalimumab Market Under COVID-19
4.10 Latin America Adalimumab Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.10.1 Latin America Adalimumab Market Under COVID-19
4.11 Middle East and Africa Adalimumab Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.11.1 Middle East and Africa Adalimumab Market Under COVID-19

5 GLOBAL ADALIMUMAB SALES VOLUME, REVENUE, PRICE TREND BY TYPE

5.1 Global Adalimumab Sales Volume and Market Share by Type (2017-2022)
5.2 Global Adalimumab Revenue and Market Share by Type (2017-2022)
5.3 Global Adalimumab Price by Type (2017-2022)
5.4 Global Adalimumab Sales Volume, Revenue and Growth Rate by Type (2017-2022)
  5.4.1 Global Adalimumab Sales Volume, Revenue and Growth Rate of Rheumatoid Arthritis (2017-2022)
  5.4.2 Global Adalimumab Sales Volume, Revenue and Growth Rate of Psoriatic Arthritis (2017-2022)
  5.4.3 Global Adalimumab Sales Volume, Revenue and Growth Rate of Psoriasis (2017-2022)
  5.4.4 Global Adalimumab Sales Volume, Revenue and Growth Rate of Crohn’s disease (2017-2022)
  5.4.5 Global Adalimumab Sales Volume, Revenue and Growth Rate of Ulcerative colitis (2017-2022)

6 GLOBAL ADALIMUMAB MARKET ANALYSIS BY APPLICATION

6.1 Global Adalimumab Consumption and Market Share by Application (2017-2022)
6.2 Global Adalimumab Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Adalimumab Consumption and Growth Rate by Application (2017-2022)
  6.3.1 Global Adalimumab Consumption and Growth Rate of Adults (2017-2022)
  6.3.2 Global Adalimumab Consumption and Growth Rate of Children (2017-2022)

7 GLOBAL ADALIMUMAB MARKET FORECAST (2022-2027)

7.1 Global Adalimumab Sales Volume, Revenue Forecast (2022-2027)
  7.1.1 Global Adalimumab Sales Volume and Growth Rate Forecast (2022-2027)
  7.1.2 Global Adalimumab Revenue and Growth Rate Forecast (2022-2027)
  7.1.3 Global Adalimumab Price and Trend Forecast (2022-2027)
7.2 Global Adalimumab Sales Volume and Revenue Forecast, Region Wise (2022-2027)
  7.2.1 United States Adalimumab Sales Volume and Revenue Forecast (2022-2027)
  7.2.2 Europe Adalimumab Sales Volume and Revenue Forecast (2022-2027)
  7.2.3 China Adalimumab Sales Volume and Revenue Forecast (2022-2027)
  7.2.4 Japan Adalimumab Sales Volume and Revenue Forecast (2022-2027)
  7.2.5 India Adalimumab Sales Volume and Revenue Forecast (2022-2027)
  7.2.6 Southeast Asia Adalimumab Sales Volume and Revenue Forecast (2022-2027)
  7.2.7 Latin America Adalimumab Sales Volume and Revenue Forecast (2022-2027)
  7.2.8 Middle East and Africa Adalimumab Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Adalimumab Sales Volume, Revenue and Price Forecast by Type (2022-2027)
  7.3.1 Global Adalimumab Revenue and Growth Rate of Rheumatoid Arthritis (2022-2027)
  7.3.2 Global Adalimumab Revenue and Growth Rate of Psoriatic Arthritis (2022-2027)
  7.3.3 Global Adalimumab Revenue and Growth Rate of Psoriasis (2022-2027)
  7.3.4 Global Adalimumab Revenue and Growth Rate of Crohn’s disease (2022-2027)
  7.3.5 Global Adalimumab Revenue and Growth Rate of Ulcerative colitis (2022-2027)
7.4 Global Adalimumab Consumption Forecast by Application (2022-2027)
  7.4.1 Global Adalimumab Consumption Value and Growth Rate of Adults(2022-2027)
  7.4.2 Global Adalimumab Consumption Value and Growth Rate of Children(2022-2027)
7.5 Adalimumab Market Forecast Under COVID-19

8 ADALIMUMAB MARKET UPSTREAM AND DOWNSTREAM ANALYSIS

8.1 Adalimumab Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
  8.3.1 Labor Cost Analysis
  8.3.2 Energy Costs Analysis
  8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Adalimumab Analysis
8.6 Major Downstream Buyers of Adalimumab Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Adalimumab Industry

9 PLAYERS PROFILES

9.1 Boehringer Ingelheim
  9.1.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Region and Competitors
  9.1.2 Adalimumab Product Profiles, Application and Specification
  9.1.3 Boehringer Ingelheim Market Performance (2017-2022)
  9.1.4 Recent Development
  9.1.5 SWOT Analysis
9.2 Novartis AG
  9.2.1 Novartis AG Basic Information, Manufacturing Base, Sales Region and Competitors
  9.2.2 Adalimumab Product Profiles, Application and Specification
  9.2.3 Novartis AG Market Performance (2017-2022)
  9.2.4 Recent Development
  9.2.5 SWOT Analysis
9.3 Pfizer
  9.3.1 Pfizer Basic Information, Manufacturing Base, Sales Region and Competitors
  9.3.2 Adalimumab Product Profiles, Application and Specification
  9.3.3 Pfizer Market Performance (2017-2022)
  9.3.4 Recent Development
  9.3.5 SWOT Analysis
9.4 Biogen
  9.4.1 Biogen Basic Information, Manufacturing Base, Sales Region and Competitors
  9.4.2 Adalimumab Product Profiles, Application and Specification
  9.4.3 Biogen Market Performance (2017-2022)
  9.4.4 Recent Development
  9.4.5 SWOT Analysis
9.5 Mylan
  9.5.1 Mylan Basic Information, Manufacturing Base, Sales Region and Competitors
  9.5.2 Adalimumab Product Profiles, Application and Specification
  9.5.3 Mylan Market Performance (2017-2022)
  9.5.4 Recent Development
  9.5.5 SWOT Analysis
9.6 AbbVie
  9.6.1 AbbVie Basic Information, Manufacturing Base, Sales Region and Competitors
  9.6.2 Adalimumab Product Profiles, Application and Specification
  9.6.3 AbbVie Market Performance (2017-2022)
  9.6.4 Recent Development
  9.6.5 SWOT Analysis
9.7 Sandoz
  9.7.1 Sandoz Basic Information, Manufacturing Base, Sales Region and Competitors
  9.7.2 Adalimumab Product Profiles, Application and Specification
  9.7.3 Sandoz Market Performance (2017-2022)
  9.7.4 Recent Development
  9.7.5 SWOT Analysis
9.8 Amgen
  9.8.1 Amgen Basic Information, Manufacturing Base, Sales Region and Competitors
  9.8.2 Adalimumab Product Profiles, Application and Specification
  9.8.3 Amgen Market Performance (2017-2022)
  9.8.4 Recent Development
  9.8.5 SWOT Analysis

10 RESEARCH FINDINGS AND CONCLUSION


11 APPENDIX

11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES

Figure Adalimumab Product Picture
Table Global Adalimumab Market Sales Volume and CAGR (%) Comparison by Type
Table Adalimumab Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Adalimumab Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Adalimumab Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Adalimumab Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Adalimumab Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Adalimumab Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Adalimumab Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Adalimumab Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Adalimumab Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Adalimumab Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Adalimumab Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Adalimumab Industry Development
Table Global Adalimumab Sales Volume by Player (2017-2022)
Table Global Adalimumab Sales Volume Share by Player (2017-2022)
Figure Global Adalimumab Sales Volume Share by Player in 2021
Table Adalimumab Revenue (Million USD) by Player (2017-2022)
Table Adalimumab Revenue Market Share by Player (2017-2022)
Table Adalimumab Price by Player (2017-2022)
Table Adalimumab Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Adalimumab Sales Volume, Region Wise (2017-2022)
Table Global Adalimumab Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Adalimumab Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Adalimumab Sales Volume Market Share, Region Wise in 2021
Table Global Adalimumab Revenue (Million USD), Region Wise (2017-2022)
Table Global Adalimumab Revenue Market Share, Region Wise (2017-2022)
Figure Global Adalimumab Revenue Market Share, Region Wise (2017-2022)
Figure Global Adalimumab Revenue Market Share, Region Wise in 2021
Table Global Adalimumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Adalimumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Adalimumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Adalimumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Adalimumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Adalimumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Adalimumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Adalimumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Adalimumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Adalimumab Sales Volume by Type (2017-2022)
Table Global Adalimumab Sales Volume Market Share by Type (2017-2022)
Figure Global Adalimumab Sales Volume Market Share by Type in 2021
Table Global Adalimumab Revenue (Million USD) by Type (2017-2022)
Table Global Adalimumab Revenue Market Share by Type (2017-2022)
Figure Global Adalimumab Revenue Market Share by Type in 2021
Table Adalimumab Price by Type (2017-2022)
Figure Global Adalimumab Sales Volume and Growth Rate of Rheumatoid Arthritis (2017-2022)
Figure Global Adalimumab Revenue (Million USD) and Growth Rate of Rheumatoid Arthritis (2017-2022)
Figure Global Adalimumab Sales Volume and Growth Rate of Psoriatic Arthritis (2017-2022)
Figure Global Adalimumab Revenue (Million USD) and Growth Rate of Psoriatic Arthritis (2017-2022)
Figure Global Adalimumab Sales Volume and Growth Rate of Psoriasis (2017-2022)
Figure Global Adalimumab Revenue (Million USD) and Growth Rate of Psoriasis (2017-2022)
Figure Global Adalimumab Sales Volume and Growth Rate of Crohn’s disease (2017-2022)
Figure Global Adalimumab Revenue (Million USD) and Growth Rate of Crohn’s disease (2017-2022)
Figure Global Adalimumab Sales Volume and Growth Rate of Ulcerative colitis (2017-2022)
Figure Global Adalimumab Revenue (Million USD) and Growth Rate of Ulcerative colitis (2017-2022)
Table Global Adalimumab Consumption by Application (2017-2022)
Table Global Adalimumab Consumption Market Share by Application (2017-2022)
Table Global Adalimumab Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Adalimumab Consumption Revenue Market Share by Application (2017-2022)
Table Global Adalimumab Consumption and Growth Rate of Adults (2017-2022)
Table Global Adalimumab Consumption and Growth Rate of Children (2017-2022)
Figure Global Adalimumab Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Adalimumab Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Adalimumab Price and Trend Forecast (2022-2027)
Figure USA Adalimumab Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Adalimumab Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Adalimumab Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Adalimumab Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Adalimumab Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Adalimumab Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Adalimumab Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Adalimumab Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Adalimumab Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Adalimumab Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Adalimumab Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Adalimumab Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Adalimumab Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Adalimumab Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Adalimumab Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Adalimumab Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Adalimumab Market Sales Volume Forecast, by Type
Table Global Adalimumab Sales Volume Market Share Forecast, by Type
Table Global Adalimumab Market Revenue (Million USD) Forecast, by Type
Table Global Adalimumab Revenue Market Share Forecast, by Type
Table Global Adalimumab Price Forecast, by Type
Figure Global Adalimumab Revenue (Million USD) and Growth Rate of Rheumatoid Arthritis (2022-2027)
Figure Global Adalimumab Revenue (Million USD) and Growth Rate of Rheumatoid Arthritis (2022-2027)
Figure Global Adalimumab Revenue (Million USD) and Growth Rate of Psoriatic Arthritis (2022-2027)
Figure Global Adalimumab Revenue (Million USD) and Growth Rate of Psoriatic Arthritis (2022-2027)
Figure Global Adalimumab Revenue (Million USD) and Growth Rate of Psoriasis (2022-2027)
Figure Global Adalimumab Revenue (Million USD) and Growth Rate of Psoriasis (2022-2027)
Figure Global Adalimumab Revenue (Million USD) and Growth Rate of Crohn’s disease (2022-2027)
Figure Global Adalimumab Revenue (Million USD) and Growth Rate of Crohn’s disease (2022-2027)
Figure Global Adalimumab Revenue (Million USD) and Growth Rate of Ulcerative colitis (2022-2027)
Figure Global Adalimumab Revenue (Million USD) and Growth Rate of Ulcerative colitis (2022-2027)
Table Global Adalimumab Market Consumption Forecast, by Application
Table Global Adalimumab Consumption Market Share Forecast, by Application
Table Global Adalimumab Market Revenue (Million USD) Forecast, by Application
Table Global Adalimumab Revenue Market Share Forecast, by Application
Figure Global Adalimumab Consumption Value (Million USD) and Growth Rate of Adults (2022-2027)
Figure Global Adalimumab Consumption Value (Million USD) and Growth Rate of Children (2022-2027)
Figure Adalimumab Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Boehringer Ingelheim Profile
Table Boehringer Ingelheim Adalimumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Boehringer Ingelheim Adalimumab Sales Volume and Growth Rate
Figure Boehringer Ingelheim Revenue (Million USD) Market Share 2017-2022
Table Novartis AG Profile
Table Novartis AG Adalimumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis AG Adalimumab Sales Volume and Growth Rate
Figure Novartis AG Revenue (Million USD) Market Share 2017-2022
Table Pfizer Profile
Table Pfizer Adalimumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Adalimumab Sales Volume and Growth Rate
Figure Pfizer Revenue (Million USD) Market Share 2017-2022
Table Biogen Profile
Table Biogen Adalimumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Biogen Adalimumab Sales Volume and Growth Rate
Figure Biogen Revenue (Million USD) Market Share 2017-2022
Table Mylan Profile
Table Mylan Adalimumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Mylan Adalimumab Sales Volume and Growth Rate
Figure Mylan Revenue (Million USD) Market Share 2017-2022
Table AbbVie Profile
Table AbbVie Adalimumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AbbVie Adalimumab Sales Volume and Growth Rate
Figure AbbVie Revenue (Million USD) Market Share 2017-2022
Table Sandoz Profile
Table Sandoz Adalimumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sandoz Adalimumab Sales Volume and Growth Rate
Figure Sandoz Revenue (Million USD) Market Share 2017-2022
Table Amgen Profile
Table Amgen Adalimumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amgen Adalimumab Sales Volume and Growth Rate
Figure Amgen Revenue (Million USD) Market Share 2017-2022


More Publications